“Several oral (beta)-blockers are U.S. Food and Drug Administration-approved for migraine prophylaxis, but their gradual absorption and modification by first-pass metabolism delays effective plasma levels for hours to days, limiting their use in acute migraines,” Matthew Cossack, M.D., of the University of Missouri-Kansas City School of Medicine, and colleagues wrote. Read more.
KC Scholars partnership also in U.S. News and World Report … Read more
Fengpeng Sun co-authored study on California wildfire seasons The 2015 … Read more
Brent Never teaches about Kansas City’s racial dividing line Never … Read more